Most of the studies present in the literature show a high prevalence, and incidence, of new cases of hypothyroidism and autoimmune thyroiditis (AT) in systemic lupus erythematosus (SLE) patients, overall in female gender. A limited number of cases of Graves’ disease have been also reported in SLE patients, in agreement with the higher prevalence of thyroid autoimmunity. It has been also demonstrated that a Th1 predominance is associated with AT in SLE patients. Furthermore, a higher prevalence of papillary thyroid cancer has been recently reported in SLE, in particular in the presence of thyroid autoimmunity. However, studies in larger number of SLE patients are needed to confirm findings about thyroid cancer. On the whole, data from literature strongly suggest that female SLE patients, with a high risk (a normal but at the higher limit thyroid-stimulating hormone value, positive antithyroid peroxidase antibodies, a hypoechoic pattern, and small thyroid), should undergo periodic thyroid function follow-up, and appropriate treatments when needed. A careful thyroid monitoring would be opportune during the follow-up of these patients.

Systemic lupus erythematosus and thyroid autoimmunity / Martina Ferrari, Silvia; Elia, Giusy; Virili, Camilla; Centanni, Marco; Antonelli, Alessandro; Fallahi, Poupak. - In: FRONTIERS IN ENDOCRINOLOGY. - ISSN 1664-2392. - 8:(2017). [10.3389/fendo.2017.00138]

Systemic lupus erythematosus and thyroid autoimmunity

Camilla Virili;Marco Centanni;
2017

Abstract

Most of the studies present in the literature show a high prevalence, and incidence, of new cases of hypothyroidism and autoimmune thyroiditis (AT) in systemic lupus erythematosus (SLE) patients, overall in female gender. A limited number of cases of Graves’ disease have been also reported in SLE patients, in agreement with the higher prevalence of thyroid autoimmunity. It has been also demonstrated that a Th1 predominance is associated with AT in SLE patients. Furthermore, a higher prevalence of papillary thyroid cancer has been recently reported in SLE, in particular in the presence of thyroid autoimmunity. However, studies in larger number of SLE patients are needed to confirm findings about thyroid cancer. On the whole, data from literature strongly suggest that female SLE patients, with a high risk (a normal but at the higher limit thyroid-stimulating hormone value, positive antithyroid peroxidase antibodies, a hypoechoic pattern, and small thyroid), should undergo periodic thyroid function follow-up, and appropriate treatments when needed. A careful thyroid monitoring would be opportune during the follow-up of these patients.
2017
systemic lupus erythematosus; autoimmune thyroiditis; hypothyroidism; graves’ disease; thyroid cancer; AbTPO; AbTg; CXCL10
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Systemic lupus erythematosus and thyroid autoimmunity / Martina Ferrari, Silvia; Elia, Giusy; Virili, Camilla; Centanni, Marco; Antonelli, Alessandro; Fallahi, Poupak. - In: FRONTIERS IN ENDOCRINOLOGY. - ISSN 1664-2392. - 8:(2017). [10.3389/fendo.2017.00138]
File allegati a questo prodotto
File Dimensione Formato  
Ferrari_Systemic-lupus-erythematosus_2017.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 174.29 kB
Formato Adobe PDF
174.29 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1204636
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 39
  • ???jsp.display-item.citation.isi??? 39
social impact